Stay updated on Quizartinib in Children & Young Adults With AML Clinical Trial
Sign up to get notified when there's something new on the Quizartinib in Children & Young Adults With AML Clinical Trial page.

Latest updates to the Quizartinib in Children & Young Adults With AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe site’s displayed revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check20 days agoChange DetectedA sitewide NIH notice announces a transition in terminology, saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.5%

- Check27 days agoChange DetectedThe footer now identifies the site as revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check34 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check55 days agoChange DetectedThe history now shows a new Revision: v3.7.0 entry, replacing the previous Revision: v3.6.6. This indicates an updated version of the page history captured for the study record.SummaryDifference0.1%

- Check76 days agoChange DetectedA new revision entry v3.6.6 was added to the study record history, replacing the previous v3.6.5 entry. This reflects an update to the record's revision history rather than changes to the study data.SummaryDifference0.1%

Stay in the know with updates to Quizartinib in Children & Young Adults With AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quizartinib in Children & Young Adults With AML Clinical Trial page.